I

Immudicon

10 employees

Immudicon is a biotechnology company that creates complement-based biologics which targets and localizes immune cells to tumors.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Immunology
Therapeutics
Immunoediting
Cancer Therapeutics
Preclinical Research

Date founded

2011

Funding rounds raised

I

Immudicon raised undisclosed on November 1, 2013

Investors: Dorm Room Fund

FAQ